These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 26677576)

  • 1. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
    Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.
    Stankiewicz-Drogoń A; Dörner B; Erker T; Boguszewska-Chachulska AM
    J Med Chem; 2010 Apr; 53(8):3117-26. PubMed ID: 20337460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells.
    Lin K; Kwong AD; Lin C
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4784-92. PubMed ID: 15561857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary screening of activity fraction of Alchornea trewioides suppresses expression of subgenomic hepatitis C virus RNA in vitro].
    Wang QR; Tao HM; Wu G; Fan Q; Huang SH; Hong F; Lv ZP
    Zhong Yao Cai; 2013 Jun; 36(6):880-3. PubMed ID: 24380267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-nucleoside inhibitors of the HCV polymerase.
    Sarisky RT
    J Antimicrob Chemother; 2004 Jul; 54(1):14-6. PubMed ID: 15190019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Replication of the subgenomic hepatitis C virus replicon in the presence of the NS3 protease inhibitors: a stochastic model].
    Ivanisenko NV; Mishchenko EL; Akberdin IR; Demenkov PS; Likhoshvai VA; Kozlov KN; Todorov DI; Samsonova MG; Samsonov AM; Kolchanov NA; Ivanisenko VA
    Biofizika; 2013; 58(5):758-74. PubMed ID: 25481944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones inhibit HCV by targeting its helicase.
    Khan IA; Siddiqui S; Rehmani S; Kazmi SU; Ali SH
    Antivir Ther; 2012; 17(3):467-76. PubMed ID: 22293206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of 1H-benzotriazole and 1H-benzimidazole analogues--inhibitors of the NTpase/helicase of HCV and of some related Flaviviridae.
    Bretner M; Baier A; Kopańska K; Najda A; Schoof A; Reinholz M; Lipniacki A; Piasek A; Kulikowski T; Borowski P
    Antivir Chem Chemother; 2005; 16(5):315-26. PubMed ID: 16245647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives.
    Peng HK; Lin CK; Yang SY; Tseng CK; Tzeng CC; Lee JC; Yang SC
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1107-10. PubMed ID: 22204909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.
    Maga G; Gemma S; Fattorusso C; Locatelli GA; Butini S; Persico M; Kukreja G; Romano MP; Chiasserini L; Savini L; Novellino E; Nacci V; Spadari S; Campiani G
    Biochemistry; 2005 Jul; 44(28):9637-44. PubMed ID: 16008349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibitors of hepatitis C virus replication.
    Neyts J
    Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIα) inhibitors as anti hepatitis C (HCV) agents.
    Leivers AL; Tallant M; Shotwell JB; Dickerson S; Leivers MR; McDonald OB; Gobel J; Creech KL; Strum SL; Mathis A; Rogers S; Moore CB; Botyanszki J
    J Med Chem; 2014 Mar; 57(5):2091-106. PubMed ID: 23944386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of Janus type nucleosides as potential HCV NS5B polymerase inhibitors.
    Zhou L; Amblard F; Zhang H; McBrayer TR; Detorio MA; Whitaker T; Coats SJ; Schinazi RF
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3385-8. PubMed ID: 23623492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of a halogen bond to binding of halogenated ligands by protein kinases].
    Poznański J
    Postepy Biochem; 2015; 61(3):311-6. PubMed ID: 26677579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasker Foundation announces award winners for 2016.
    Mohammadi D
    Lancet; 2016 Sep; 388(10050):1144-5. PubMed ID: 27637673
    [No Abstract]   [Full Text] [Related]  

  • 17. IPK2019: David Shugar and the genesis of the IPK conferences.
    Pinna LA
    IUBMB Life; 2020 Jun; 72(6):1097-1102. PubMed ID: 32031322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms.
    Pucko EB; Ostrowski RP
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The specific enzyme inhibitors for potential therapeutic use].
    Bretner M
    Postepy Biochem; 2015; 61(3):292-7. PubMed ID: 26677576
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.